MD Anderson Research Highlights for November 30, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and...
MD Anderson Research Highlights for November 16, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and...
MD Anderson and Exscientia launch strategic collaboration...
The University of Texas MD Anderson Cancer Center and Exscientia plc today announced a strategic collaboration to align the drug...
Eyal Gottlieb, Ph.D., to join MD Anderson as Vice President for...
The University of Texas MD Anderson Cancer Center today announced that Eyal Gottlieb, Ph.D., has been named the institution’s vice...
Nanotechnology platform enables immune conversion of cancer...
A team of researchers at The University of Texas MD Anderson Cancer Center has developed a nanotechnology platform that can change the...
MD Anderson Research Highlights: SITC 2022 Special Edition
ABSTRACTS: 374, 568, 590, 657, 659, 782
The University of Texas MD Anderson Cancer Center’s...
Shorter course of radiation therapy yields comparable...
Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated...
MD Anderson Research Highlights for November 3, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and...
Hormone therapy could lower risk of...
A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center and the University of California San...